Back to Search
Start Over
Infarct-Related Coronary Artery Patency and Medication Use Prior to ST-Segment Elevation Myocardial Infarction
- Source :
-
American Journal of Cardiology . Jan2006, Vol. 97 Issue 1, p7-9. 3p. - Publication Year :
- 2006
-
Abstract
- In patients who have ST-segment elevation myocardial infarction (STEMI), a patent infarct-related artery on the initial angiogram is associated with improved clinical outcomes, including decreased mortality. The present study assessed the influence of administering aspirin, β blockers, statins, and angiotensin-converting enzyme inhibitors before STEMI on infarct-related artery patency. Our data demonstrate that patients who have STEMI and receive these medications on an outpatient basis before the event have a higher likelihood of having a patent infarct-related artery compared with patients who do not receive these medications. Further, our data demonstrate a graded association according to the number of such medications being administered: the likelihood of a patent infarct-related artery increased to >50% as the number of these medications increased. [Copyright &y& Elsevier]
Details
- Language :
- English
- ISSN :
- 00029149
- Volume :
- 97
- Issue :
- 1
- Database :
- Academic Search Index
- Journal :
- American Journal of Cardiology
- Publication Type :
- Academic Journal
- Accession number :
- 19306853
- Full Text :
- https://doi.org/10.1016/j.amjcard.2005.07.103